SLC7A11 and hepatoblastoma: Similarly, in hepatoblastoma, METTL3-mediated m6A modification increases the stability and expression of SLC7A11 mRNA, conferring resistance to ferroptosis and accelerating tumor growth (Liu L. et al., 2022).